ModelEdge
Scinai Immunotherapeutics Ltd
SCNI
Filing type
20-F
Filing date
Mar 31, 2026
Updated
Apr 1, 2026 ยท 5:36 AM

Filing

20-FAnnual and Transition Report of Foreign Private Issuers

Exhibits

EX-1.1AMENDED AND RESTATED ARTICLES OF ASSOCIATION OF SCINAI IMMUNOTHERAPEUTICS LTDEX-2.3DESCRIPTION OF SHARE CAPITALEX-4.16LEASE AGREEMENT DATED AUGUST 11, 2020, BETWEEN SCINAI BIOPHARMA AND P L.A.R. MANAGEMENT ASSETS LTD. AND R. MATRY ADV.ATTORNEY COMPANYEX-8.1LIST OF SUBSIDIARIES OF THE COMPANYEX-12.1CERTIFICATIONEX-12.2CERTIFICATIONEX-13.1CERTIFICATIONEX-13.2CERTIFICATIONEX-15.1CONSENT OF ZIV HAFT, CERTIFIED PUBLIC ACCOUNTANTS IN ISRAEL AND A MEMBER OF BDO, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE REGISTRANTGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic